Key Takeaways

• Drug manufacturers can be held liable when a medication causes injury the company knew or should have known about and failed to warn patients and doctors.
• Pharmaceutical cases are usually consolidated in a federal Multidistrict Litigation (MDL) or a state coordinated proceeding — which means evidence and discovery are shared across thousands of cases, lowering the cost of pursuing an individual claim.
• Most pharmaceutical injury claims run on a statute-of-limitations clock of two or three years, depending on the state and when the link between the drug and the injury became known. Acting early protects your rights.
• There are no up-front costs. We review every pharmaceutical injury claim on a contingency basis — you pay nothing unless we recover money for you.
• Our firm is actively reviewing claims involving Ozempic and other GLP-1 drugs, Depo-Provera, talcum powder, chemical hair relaxers, the Paragard IUD, Tylenol/acetaminophen use during pregnancy, and the Bard PowerPort catheter.

Pharmaceutical Injury Lawyer Serving PA, NJ, NY, and MD

Every year, drugs that were sold as safe and effective end up causing serious injuries — cancers, strokes, brain tumors, organ damage, birth defects, and death. When that happens, patients and families have a right to hold the manufacturer accountable. Siddons Law Firm represents injured clients throughout Pennsylvania, New Jersey, New York, and Maryland in claims against pharmaceutical companies, generic drug makers, and medical device manufacturers.

Pharmaceutical litigation is technical, document-heavy, and expensive to pursue alone — which is exactly why federal courts group these cases into MDLs and plaintiffs’ firms work together on shared discovery. Our job is to make sure your individual claim is filed in the right forum, that your medical records and pharmacy records are preserved, and that you’re represented by attorneys with the resources to take your case all the way through settlement or trial if that’s what it takes.

Drugs and Medical Products We Are Currently Reviewing

Below are the pharmaceutical and medical-device cases our firm is actively accepting, along with the intake parameters we use to qualify potential claims. If your situation falls outside one of these parameters but you believe a medication or device caused you harm, please still contact us — many cases require a closer review of records before we can give you a definitive answer.

Ozempic, Wegovy, Mounjaro and Other GLP-1 Drugs

GLP-1 receptor agonists — sold as Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Trulicity, Saxenda, and Victoza — have been prescribed to more than 30 million Americans for diabetes and weight loss. Patients are now reporting severe gastrointestinal injuries (gastroparesis, intestinal obstruction, ileus), a sudden form of vision loss called NAION, gallbladder disease, and blood-clotting events. Two separate federal MDLs are now consolidating thousands of cases.

Who qualifies:

• Took a brand-name GLP-1 medication (Ozempic, Wegovy, Rybelsus, Mounjaro, Trulicity, Zepbound, Saxenda, or Victoza). Compounded semaglutide from a compounding pharmacy is not eligible.
• Took the medication for at least 30 days.
• Diagnosed and medically treated for one of the following injuries: gastroparesis, ileus or bowel obstruction, intraoperative pulmonary aspiration, esophageal injury requiring surgery, gallbladder removal, NAION (sudden vision loss), DVT or pulmonary embolism, kidney injury caused by dehydration, GI injury requiring surgery, cyclic vomiting lasting four weeks or longer, malnutrition disorders, Wernicke encephalopathy, clinically significant vitamin deficiencies, acute necrotizing encephalopathy, or suicide (medical treatment is not required for suicide claims).
• Usage began before the FDA’s label-update cutoff for the relevant injury — for example, Ozempic gallbladder claims must have started before March 2022; Mounjaro pulmonary aspiration claims before January 2024; Ozempic severe-GI-reaction claims before January 2025.
• No prior abdominal surgery on or near the stomach that may have injured the vagus nerve.
• Pancreatitis-only or pancreatic-cancer-only claims are not currently accepted unless paired with another qualifying injury.

Take the full GLP-1 intake screening →

Depo-Provera (Brain Tumors / Meningioma)

In December 2025 the FDA added a new warning to Depo-Provera linking the contraceptive injection to an increased risk of meningioma, a type of brain tumor. Women who received Depo-Provera shots and were later diagnosed with a meningioma may be eligible for compensation.

Who qualifies:

• Received Depo-Provera or Depo-SubQ Provera 104 contraceptive injections for 12 months or longer.
• Diagnosed with intracranial or spinal meningioma after Depo-Provera use.
• Diagnosis confirmed by MRI, CT, or pathology report.
• Statute of limitations has not run in your state of residence (typically two to three years from diagnosis or discovery).

Learn more about Depo-Provera claims →

Talcum Powder (Ovarian Cancer and Mesothelioma)

Decades of internal company documents show that talc-based powders sold by Johnson & Johnson and others were marketed to women without warning of the asbestos-contamination risk and the link to ovarian cancer and mesothelioma.

Who qualifies:

• Female client. (Deceased-client cases are not currently accepted.)
• Used Johnson’s Baby Powder or Shower-to-Shower (brand-name, not generic) in the genital area.
• Five or more years of regular use.
• Diagnosed with ovarian cancer within the last two years.
• No prior diagnosis of cervical or endometrial cancer.

Chemical Hair Relaxers (Uterine and Ovarian Cancer)

Chemical hair relaxers and straighteners — including Dark and Lovely, Just for Me, Olive Oil, Optimum Care, Soft & Beautiful, and similar products — are linked to uterine cancer, uterine fibroids, endometrial cancer, and ovarian cancer in long-term users. Cases are consolidated in the Northern District of Illinois MDL.

Who qualifies:

• Used chemical hair relaxers regularly (at least four applications per year) for one year or longer.
• Diagnosed with uterine cancer, endometrial cancer, ovarian cancer, or uterine fibroids that required hysterectomy.
• Diagnosis confirmed by pathology.
• Able to identify the brand(s) of relaxer used.

Paragard IUD (Breakage on Removal)

The Paragard copper IUD has been linked to breakage during removal, often leaving fragments embedded in the uterus and requiring surgery, hysterectomy, or causing fertility loss.

Who qualifies:

• Had a Paragard copper IUD inserted.
• The device broke during or after removal.
• Required additional medical procedures — hysteroscopy, laparoscopy, dilation and curettage, or hysterectomy — to remove the broken fragment.
• Medical records document the broken IUD and the corrective procedure.

Learn more about Paragard IUD claims →

Tylenol / Acetaminophen Use During Pregnancy (Autism and ADHD)

The federal Tylenol MDL has narrowed substantially after recent Daubert rulings, but viable cases remain in select state-court venues. We continue to evaluate Tylenol acetaminophen cases on a case-by-case basis where the strength of the medical record supports a claim.

Who may qualify:

• Used Tylenol or store-brand acetaminophen during pregnancy, with frequency and duration of use documented.
• Child diagnosed with autism spectrum disorder or ADHD.
• Diagnosis is documented by a qualified physician or developmental specialist.
• Statute of limitations has not run in the state where the child was born or diagnosed.

Bard PowerPort (Implanted Catheter Failures)

The Bard PowerPort and AngioDynamics SmartPort are totally-implantable venous-access devices used to deliver chemotherapy, antibiotics, and other long-term IV medications. The catheter component has been linked to fractures, migration into the heart or pulmonary arteries, blood clots, and serious infections. Bellwether trials are scheduled throughout 2026.

Who qualifies:

• Implanted with a Bard PowerPort or AngioDynamics SmartPort (TIVAD), used for chemotherapy or other IV-medication delivery — not for dialysis.
• Implant occurred in 2008 or later (earlier implants only with available medical records).
• Hospitalized or required medical treatment for organ perforation, blood clots, embolism, infection lasting more than 30 days, or other serious port-related complication.
• Implant card, serial number, operative report, or other medical records that confirm the device manufacturer and model are available.

Other Drugs and Devices Under Review

Our firm is also reviewing claims involving the following medications and devices. Each comes with its own intake parameters; the bullets below summarize the minimum facts our intake team needs before opening a file.

• Suboxone — severe dental decay and tooth loss linked to the sublingual film. Qualifying claims involve documented dental injury after at least six months of Suboxone film use.
• Zantac (ranitidine) — cancer claims pending in Delaware and California state court. Qualifying claims involve regular Zantac use prior to its 2020 recall and a subsequent diagnosis of bladder, stomach, esophageal, liver, or pancreatic cancer.
• Dupixent — cutaneous T-cell lymphoma and other rare cancer diagnoses following at least six months of Dupixent therapy.
• Paraquat — Parkinson’s disease in agricultural and landscape workers. Qualifying claims require a confirmed Parkinson’s diagnosis in a person who applied Paraquat as a licensed applicator or worked at, lived near, or routinely traveled past commercial farms where Paraquat was applied.
• SSRIs during pregnancy — congenital birth defects diagnosed in a child whose mother used Paxil, Zoloft, Prozac, Lexapro, or Celexa during pregnancy.
• Proton pump inhibitors (Nexium, Prilosec, Prevacid) — chronic kidney disease or kidney failure diagnosed after at least one year of regular PPI use.

If you took a medication or were implanted with a medical device that is not listed above and you believe it caused you harm, contact our intake team — new MDLs and case calls are evaluated on a rolling basis.

Who Can File a Pharmaceutical Injury Claim?

You may have a claim if all four of the following are true:

1. You took the drug or were implanted with the device.
2. You were diagnosed with a serious injury that has been linked to the drug or device — usually one that required hospitalization, surgery, or ongoing medical care.
3. You can document both the use and the diagnosis through medical records, pharmacy records, or insurance claims data.
4. The injury occurred within the statute of limitations for your state (typically two years in PA and NJ, three years in NY and MD, measured from when the link between the drug and the injury became known, not necessarily from when the drug was taken).

Even if you aren’t sure whether your case qualifies, the consultation is free. We’d rather hear from you and tell you “you don’t have a claim” than have you miss a filing deadline because no one looked at the facts.

How Pharmaceutical Injury Cases Work

Pharmaceutical injury claims are handled differently than car crash or slip-and-fall cases. Here’s what to expect:

1. Case evaluation. We collect the drug name and dates of use, your diagnosis, and your treating providers. No cost, no obligation.
2. Medical record review. We order your pharmacy and medical records to confirm the drug exposure and the injury diagnosis.
3. Filing. Your case is filed into the appropriate MDL or state coordinated proceeding. This preserves your claim against the statute of limitations.
4. Discovery. Bellwether trials test the strongest cases in front of juries. Those verdicts (or the risk of them) drive settlement negotiations.
5. Resolution. Most pharmaceutical cases resolve through a settlement grid that assigns values based on injury severity, age, and dose/duration. Cases can also settle individually or go to trial.

Pharmaceutical cases take time — usually 18 months to several years from filing to resolution. But because our fee is contingent, our interests and yours are aligned from day one.

Why Choose the Siddons Law Firm

Pharmaceutical litigation is not something you hand off to just any personal injury lawyer. Our firm has the experience, the resources, and the multi-state licensing to represent pharmaceutical injury clients across Pennsylvania, New Jersey, New York, and Maryland. In complex drug cases, your case is backed by the same expert witnesses, scientific consultants, and litigation databases that drive the biggest MDL verdicts in the country. You still get a local PA/NJ/NY/MD lawyer who returns your calls and explains what’s happening, but you get the firepower of a national pharmaceutical litigation team behind you.

No up-front costs. No hourly billing. Free case evaluation. You pay nothing unless we recover money for you.

Frequently Asked Questions

How long do I have to file a pharmaceutical injury lawsuit?

In most of the states we serve, you have two to three years from the date you knew or reasonably should have known that the drug or device caused your injury. Pennsylvania and New Jersey apply a two-year statute; New York and Maryland are three years. There are exceptions — for minors, for wrongful-death claims, and for discovery-rule cases — so don’t assume your case is too old until an attorney has reviewed it.

I already threw away the pill bottle. Can I still file a claim?

Yes. Pharmacy records, insurance claim data, and doctor’s notes are usually enough to establish that you took the drug. We obtain these records for you at no cost as part of the case evaluation.

How much does it cost to hire you for a pharmaceutical case?

Nothing up front. We work on a contingency fee, meaning we only get paid if we recover money for you. If we lose, you owe us nothing — no legal fees, no costs, no case expenses.

Will I have to travel to file my case?

Almost never. Most MDLs are handled through written discovery and remote depositions. In the rare case where a bellwether trial needs in-person testimony, we cover travel and accompany you throughout.

What if the drug was a generic?

Generic drug claims are more complicated because of a 2011 Supreme Court decision (PLIVA v. Mensing), but they are not impossible. Design-defect claims, failure to communicate FDA-required warning updates, and claims against the brand-name manufacturer under “innovator liability” remain viable in several states. Call us — don’t assume your case is dead just because the pharmacy dispensed a generic.

Can I participate in the class action and the MDL at the same time?

Most pharmaceutical cases are not class actions — they are mass torts, which means each plaintiff has an individual case that is coordinated (not combined) with thousands of others. You maintain your own claim and your own recovery. You do not need to “join” a class, and you are not bound by a class-action settlement unless you affirmatively participate.

Does it matter which state I live in?

It can matter. State law governs the statute of limitations, damages caps (in medical-device claims), and sometimes the forum where your case can be filed. Our firm is licensed to represent clients throughout PA, NJ, NY, and MD, so we handle those jurisdictional questions for you.

Start Your Case — Serving Clients Throughout PA, NJ, NY, and MD

If you suspect a medication or medical device caused you or a loved one serious injury, don’t wait. Call the Siddons Law Firm at (610) 255-7500, email msiddons@siddonslaw.com, or use the form on this page. Your case evaluation is free, confidential, and carries no obligation.